Amrize Ltd
AMRZ· NYSE
AMRZAmrize Ltd
Filed Aug 10, 2026 · 10-Q · 41 days after period end · 0002035989-26-000067
| Metric | Q2 2026 | Q2 2025 | Q2 2024 |
|---|---|---|---|
| Revenue | $3.49B | $3.22B | $3.24B |
| Net Income | $478.00M | $417.00M | $474.00M |
| EPS Diluted | $0.86 | $0.75 | $0.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amrize Ltd · CIK 2035989 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end
